商品名：Ibaflin
Inhibits the enzyme DNA gyrase. Its bactericidal action is concentration-dependent as reflected by the once daily dosing regime.
Ideally fluoroquinolone use should be reserved for infections where culture and sensitivity testing predicts a clinical response and where first- and second-line antimicrobials would not be effective. Ibafloxacin has a broad spectrum of activity. It is active against mycoplasmas, many Gram-negative organisms and some Gram- positive organisms, including Pasteurella, Staphylococcus, Pseudomonas aeruginosa, Klebsiella, Escherichia coli, Proteus and Salmonella. It is effective against beta-lactamase
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
執行前須核對 ibafloxacin 活性物、外消旋或對映異構物層次、實際成品、配方、強度與現行法域狀態。 須逐案核對物種、年齡與生長狀態、感染部位、培養或藥敏、腎肝與神經系統背景、繁殖狀態及其他用藥。 適應症、給藥途徑、療程、劑量、監測、停藥或換藥與交互作用，只能由獸醫依現行當地標示及個案檢查重建。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
70-80%